Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence, Risk Factor and Clinical Significance of Hepatitis D Virus Infection Among Targeted High Risk Population in Thailand: Nationwide Survey 2022-2024

NCT05350865 is registered in ClinicalTrials.gov with The HIV Netherlands Australia Thailand Research Collaboration as lead sponsor.

NCT NCT05350865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05350865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence, Risk Factor and Clinical Significance of Hepatitis D Virus Infection Among Targeted High Risk Population in Thailand: Nationwide Survey 2022-2024
Lead sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Phase
Observational
Overall status
Completed
Start date
January 30, 2023
Completion date
May 1, 2025
Enrollment
3,296 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hdv